Bo Liu

20PUBLICATIONS

11CO-AUTHORS

Molecular targetsPharmacogenomicsBiologically active moleculesCell development, proliferation and deathLegal ethics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|May 31, 2026

Discovery of a novel dual-target modulator of ULK1 and ERK1/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70/Cav-1/MMPs axis.

|May 11, 2026

Integrated clinical and computational data-based repurposing of econazole as a novel autophagic activator in ULK1-related Parkinson disease.

|May 21, 2024

Rethinking therapeutic strategies of dual-target drugs: An update on pharmacological small-molecule compounds in cancer.

Yiren Yang, Yi Mou, Lin-Xi Wan

|Jan 30, 2023

Targeting regulated cell death with plant natural compounds for cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death, and necroptosis.

Yuanyuan Yang, Yanmei Chen, Jun Hao Wu

|Jan 30, 2023

Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research.

Xiang Li, Qian Liu, Xin Xie

|Oct 07, 2022

Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors.

Leilei Fu, Siwei Chen, Gu He

Pageof 4

Frequent Collaborators

Liang Ouyang

Gu He

Guan Wang

Cheng-Ming Chiang

Lingjuan Zhu

Leilei Fu

Siwei Chen

Cheng Peng

Bo Han

Haiyang Yu

Frequent Collaborators

Liang Ouyang

Gu He

Guan Wang

Cheng-Ming Chiang